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Alcohol drinking habits and alcoholism are partly genetically determined.
Alcohol is degraded primarily by alcohol dehydrogenase (ADH) wherein
genetic variation that affects the rate of alcohol degradation is found in
ADH1B and ADH1C. It is biologically plausible that these variations may be
associated with alcohol drinking habits and alcoholism. By genotyping 9080
white men and women from the general population, we found that men and
women with ADH1B slow vs fast alcohol degradation drank more alcohol and
had a higher risk of everyday drinking, heavy drinking, excessive drinking and
of alcoholism. For example, the weekly alcohol intake was 9.8 drinks (95%
confidence interval (CI): 9.1–11) among men with the ADH1B 1/1 genotype
compared to 7.5 drinks (95% CI: 6.4–8.7) among men with the ADH1B 1/2
genotype, and the odds ratio (OR) for heavy drinking was 3.1 (95% CI: 1.7–
5.7) among men with the ADH1B 1/1 genotype compared to men with the
ADH1B 1/2 genotype. Furthermore, individuals with ADH1C slow vs fast
alcohol degradation had a higher risk of heavy and excessive drinking. For
example, the OR for heavy drinking was 1.4 (95% CI: 1.1–1.8) among men
with the ADH1C 1/2 genotype and 1.4 (95% CI: 1.0–1.9) among men with
the ADH1B 2/2 genotype, compared with men with the ADH1C 1/1
genotype. Results for ADH1B and ADH1C genotypes among men and
women were similar. Finally, because slow ADH1B alcohol degradation is
found in more than 90% of the white population compared to less than 10%
of East Asians, the population attributable risk of heavy drinking and
alcoholism by ADH1B 1/1 genotype was 67 and 62% among the white
population compared with 9 and 24% among the East Asian population.
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Introduction
Alcoholism and alcohol drinking in general represent huge public health
problems in most countries worldwide, preventing many individuals from
successfully holding a job or looking after a family. In addition, excessive alcohol
use leads to diseases such as liver cirrhosis, chronic pancreatitis, upper
gastrointestinal cancers, cardiomyopathy, polyneuropathy and dementia. It has
been shown in twin studies that heritability explains approximately 50% of
alcoholism and problem drinking in the white population.1,2
The region surrounding the alcohol dehydrogenase (ADH) gene cluster is
known to be associated with alcoholism from whole-genome scans.3 Well-known
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functional polymorphisms of ADH1B and ADH1C may
explain this finding because the ADH1B 2 vs the ADH1B 1
allele confer a 38-fold increase in in vitro alcohol degradation
rate (that is, the conversion of ethanol to acetaldehyde) and
the ADH1C 1 vs the ADH1C  2 allele confer a 2.5-fold
increase in in vitro alcohol degradation rate.4
During alcohol degradation, acetaldehyde is only found
in low concentrations. If concentrations become high, for
example, during treatment with disulfiram (used in some
countries to prevent alcohol intake among alcoholics) or in
individuals with a defective acetaldehyde dehydrogenase
(found among Asians), individuals experience severe nausea
and flushing and automatically abstain from drinking
alcohol. It is possible that similar but less pronounced
responses to alcohol are more likely to be produced among
individuals carrying the fast alcohol degradation ADH1B 2
and ADH1C 1 alleles compared to individuals carrying the
slow alcohol degradation ADH1B  1 and ADH1C 2 alleles. If
so, individuals with slow alcohol degradation may be able to
drink larger quantities of alcohol without experiencing
discomfort due to elevated acetaldehyde levels, and conse-
quently are more likely to use alcohol excessively and to
develop alcoholism. This issue has been addressed in
different populations in case–control settings where allele
frequencies of ADH1B and ADH1C are compared between
alcoholics and nonalcoholics.5–28 To our knowledge, this
has not been studied in a prospective setting in the general
white population and it is unknown if the ADH1B and
ADH1C polymorphisms are associated with alcohol drinking
habits, such as amount of usual intake.
In the present study, we have genotyped a sample of 9080
men and women from the general white population to test
the hypotheses that slow alcohol degradation ADH1B 1 and
ADH1C  2 alleles are associated with alcohol drinking habits
and with increased risk of alcoholism.
Results
The frequencies of the ADH1B and ADH1C alleles coding for
slow alcohol degradation was 0.98 (ADH1B 1) and 0.42
(ADH1C  2) (Table 1). Genotypes were in Hardy–Weinberg
equilibrium (P¼ 0.8 for ADH1B genotypes and P¼0.7 for
ADH1C genotypes by w2-test). ADH1B 2 were associated
with ADH1C  1 (linkage disequilibrium coefficients D0 ¼0.90
and r2¼0.012).
For ADH1B, we found that men and women who were
homozygous for the slow alcohol degrading ADH1B 1 allele
had a higher alcohol intake than men and women who were
fast alcohol degrading ADH1B 2 heterozygotes or homo-
zygotes. For example, men with the ADH1B 1/1 genotype
drank on average 9.8 drinks per week (95% confidence
interval (CI): 9.1–11) and men with the ADH1B 1/2
genotype drank on average 7.5 drinks per week (95% CI:
6.4–8.7) (Table 2). Furthermore, odds for any, daily, heavy
and excessive alcohol drinking were 2–4 times higher
among men and women who were ADH1B 1 homozygotes
than among men and women who were ADH1B 2 hetero-
or homozygotes.
Using the brief Michigan Alcoholism Screening Test (brief
MAST) we found that men with the slow alcohol degrada-
tion ADH1B 1/1 genotype had a two- to fourfold risk of
alcoholism compared to men with the fast alcohol degrada-
tion ADH1B 2/1 or ADH1B 2/2 genotypes (Table 2). The
hazard ratio of hospitalization for alcoholism in men and
women with the slow alcohol degradation ADH1B 1/1
genotype was 3.9 (95% CI: 1.0–16) and 2.7 (95% CI: 0.4–20).
For ADH1C, odds for heavy and excessive alcohol drinking
were 40–70% higher among men who were hetero- or
homozygous for the slow alcohol degrading ADH1C 2 allele
than among men who were homozygous for the fast alcohol
degrading ADH1C  1 allele (Table 3). Similar results were
found in women; however, effect sizes were slightly smaller
and only statistically significant for heavy drinking. ADH1C
genotype was not associated with alcoholism (Table 3).
Analyses on daily, heavy and excessive drinking and on
alcoholism (MAST score and hospitalizations) were repeated
excluding consistent nondrinkers, that is, participants who
reported no alcohol intake at every examination in which
they participated (7.5% of the total study population). This
restriction did not affect any of our results (data not shown).
Because of linkage disequilibrium between the ADH1B 2
and ADH1C 1 alleles, and the relatively large effect on
enzyme activity of the ADH1B polymorphism, our results for
ADH1C could be influenced by ADH1B genotype. Therefore,
ADH1C analyses were repeated solely on individuals who
were ADH1B 1 homozygotes (95% of the study cohort): we
found similar results, indicating that the effect of ADH1C
genotype was independent of ADH1B genotype (data not
shown).
We also performed analyses on genotype combinations,
ranking genotypes in order of expected total enzyme
Table 1 Distribution of ADH1B and ADH1C genotypes
ADH1B ADH1C
Men (n¼4039) Women (n¼5041)
1/1 (fast) 1/2 (intermediate) 2/2 (slow) 1/1 (fast) 1/2 (intermediate) 2/2 (slow)
1/1 (slow) 1272 1882 697 1570 2347 907
1/2 (intermediate) 110 70 5 130 81 3
2/2 (fast) 2 1 0 3 0 0
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Table 3 Associations between ADH1C genotype and alcohol drinking habits and alcoholism
ADH1C alcohol
degradation
Men (n¼4039) Women (n¼5041)
1/1 (n¼1384)
(fast)
1/2 (n¼1953)
(intermediate)
2/2 (n¼702)
(slow)
1/1 (n¼1703)
(fast)
1/2 (n¼2428)
(intermediate)
2/2 (n¼910)
(slow)
Alcohol drinking habits
Weekly alcohol
intake
(n¼3784 M, 4052 W)a
9.8 (9.1–11) 10.4 (9.4–12) 10.5 (9.4–12) 4.0 (3.7–4.3) 4.1 (3.7–4.5) 4.1 (3.7–4.6)
Any alcohol intake
(n¼3784 M, 4052 W)b
1.0 (reference) 1.3 (0.9–1.8) 0.7 (0.5–1.2) 1.0 (reference) 1.1 (0.9–1.4) 1.0 (0.7–1.4)
Daily drinking
(n¼2015 M, 1259 W)b
1.0 (reference) 1.1 (0.9–1.4) 1.1 (0.8–1.5) 1.0 (reference) 1.2 (0.9–1.5) 1.2 (0.9–1.7)
Heavy drinking
(n¼1262 M, 814 W)b
1.0 (reference) 1.4 (1.1–1.8) 1.4 (1.0–1.9) 1.0 (reference) 1.3 (1.0–1.7) 1.2 (0.8–1.7)
Excessive drinking
(n¼507 M, 353 W)b
1.0 (reference) 1.6 (1.1–2.3) 1.7 (1.1–2.6) 1.0 (reference) 1.4 (0.9–2.1) 1.0 (0.6–1.6)
Alcoholism
bMAST score X5
(n¼1076 M, 597 W)b
1.0 (reference) 1.0 (0.8–1.3) 1.0 (0.7–1.4) 1.0 (reference) 0.8 (0.5–1.2) 0.8 (0.5–1.5)
bMAST score X10
(n¼290 M, 65 W)b
1.0 (reference) 1.0 (0.7–1.3) 1.0 (0.7–1.6) 1.0 (reference) 0.6 (0.3–1.0) 0.7 (0.3–1.5)
Hospitalization
(n¼209 M, 90 W)c
1.0 (reference) 1.2 (0.9–1.7) 0.9 (0.6–1.5) 1.0 (reference) 1.4 (0.8–2.6) 2.2 (1.2–4.2)
Abbreviations: bMAST, the brief Michigan Alcoholism Screening Test; M, men; W, women.
Heavy drinking was defined as drinking more than 21 drinks per week for men and 14 drinks per week for women, and excessive drinking as drinking more than 35
drinks per week for men and 21 drinks per week for women. n indicates the number of men and women who are cases in the respective analyses. Adjustment was made
for ADH1B genotype, age, years of school education and examination year.
aShown numbers are mean number of drinks per week (95% CI), which is estimated among those who report any alcohol intake.
bShown numbers are OR (95% CI).
cShown numbers are hazard ratios (95% CI).
Table 2 Associations between ADH1B genotype and alcohol drinking habits and alcoholism
ADH1B alcohol degradation Men (n¼4039) Women (n¼5041)
1/2+2/2 (n¼188) (fast)1/1 (n¼3851) (slow)1/2+2/2 (n¼217) (fast)1/1 (n¼4824) (slow)
Alcohol drinking habits
Weekly alcohol intake (n¼ 3784 M, 4052 W)a 7.5 (6.4–8.7) 9.8 (9.1–11) 3.0 (2.6–3.5) 4.0 (3.7–4.3)
Any alcohol intake (n¼3784 M, 4052 W)b 1.0 (reference) 2.1 (1.0–4.5) 1.0 (reference) 3.1 (1.8–5.3)
Daily drinking (n¼2015 M, 1259 W)b 1.0 (reference) 2.5 (1.5–4.1) 1.0 (reference) 1.9 (1.1–3.5)
Heavy drinking (n¼1262 M, 814 W)b 1.0 (reference) 3.1 (1.7–5.7) 1.0 (reference) 3.0 (1.4–6.4)
Excessive drinking (n¼507 M, 353 W)b 1.0 (reference) 2.7 (1.1–6.5) 1.0 (reference) 4.2 (1.3–13)
Alcoholism
bMAST score X5 (n¼351 M, 105 W)b 1.0 (reference) 2.9 (1.3–6.6) 1.0 (reference) 1.7 (0.5–5.2)
bMAST score X10 (n¼217 M, 55 W)b 1.0 (reference) 2.6 (1.0–7.1) 1.0 (reference) 2.8 (0.4–20)
Hospitalization (n¼167 M, 74 W)c 1.0 (reference) 3.9 (1.0–16) 1.0 (reference) 2.7 (0.4–20)
Abbreviations: bMAST, the brief Michigan Alcoholism Screening Test; M, men; W, women.
Heavy drinking was defined as drinking more than 21 drinks per week for men and 14 drinks per week for women, and excessive drinking as drinking more than 35
drinks per week for men and 21 drinks per week for women. n indicates the number of men and women who are cases in respective analyses. Adjustment was made for
ADH1C genotype, age, years of school education and examination year.
aShown numbers are mean number of drinks per week (95% CI), which is estimated among those who report any alcohol intake.
bShown numbers are OR (95% CI).
cShown numbers are hazard ratios (95% CI).
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activity, and tested for linear trend in each of the variables
for alcohol drinking habits and alcoholism (Figure 1). For
most end points, there was a statistically significant trend
test in the expected direction: individuals with slow vs fast
alcohol degradation drank more alcohol and more often,
and had a higher risk of alcoholism.
ADH1B genotypes are very differently distributed among
whites and East Asian populations (Figure 2). Among the
white population, more than 90% carry the ADH1B 1/1
genotype, coding for slow alcohol degradation, whereas
among the East Asian population less than 10% carry this
genotype. Hence, the population attributable risk of heavy
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Figure 1 Association between the combined ADH1B and ADH1C genotypes and alcohol drinking habits and alcoholism. The combined ADH1B and
ADH1C genotypes are ranked according to expected enzyme activity ((ADH1B 2/1þADH1B 2/2, ADH1C 1/1) 4(ADH1B 2/1þADH1B 2/2,
ADH1C 2/1þADH1C 2/2) 4(ADH1B 1/1, ADH1C 1/1) 4(ADH1B 1/1, ADH1C 1/2) 4(ADH1B 1/1, ADH1C 2/2)). ADH1C 1/2 and ADH1C 2/2
were combined because of few subjects in these categories among the ADH1B 2 hetero- and homozygotes. Analyses are for men and women
combined and P-values are for linear trend tests.
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drinking and alcoholism according to the ADH1B 1/1
genotype is 67 and 62% among white population compared
with 9 and 24% among the East Asian population.
Discussion
Our results suggest that ADH1B and ADH1C genotypes are
associated with alcoholism and alcohol drinking habits.
Men and women with ADH1B slow vs fast alcohol degrada-
tion drank more alcohol, were more often daily, heavy and
excessive drinkers and had higher risks of alcoholism.
Men and women with ADH1C intermediate and slow vs
fast alcohol degradation were more often heavy and
excessive drinkers. As expected, effect sizes were smaller
for ADH1C than for ADH1B, but given the high frequency of
the ADH1C 2 allele, it is nevertheless a very interesting
finding. Moreover, the impact of the ADH1C 2 allele on
cumulative lifetime alcohol intake may be significant. Our
results also suggest that ADH1B and ADH1C genotypes may
partly explain why white people generally drink more
alcohol than East Asian. The population risk of heavy
drinking and alcoholism attributable to the ADH1B 1/1
genotype was 67 and 62% among white population and
only 9 and 24% among the East Asian population.
Among men, we found relative estimates for alcoholism
from two to three among ADH1B 1 homozygotes, which is
comparable to results from a recent meta-analysis consisting
predominantly of East Asian studies.29 Also, the odds ratio
(OR) for heavy drinking for men was 3.1 which agrees with
what is previously found among Asian men.30 Separate
estimates for women were not available for any of the end
points in previous studies. Our results were remarkably
similar for men and women indicating that the investigated
associations are not sex-specific.
The various end points were probably subject to some
misclassification, that is, sensitivity and/or specificity less
than 100%. Measures of heavy and excessive drinking will
be misclassified if amount of alcohol intake is under- or
overreported, which it in many instances probably is. The
MAST score is not a perfect screenings tool for alcoholism
either. However, these errors occur most likely indepen-
dently of genotype, and because end points are binary, will
lead to bias toward the null.31 Hence, we do not consider
misclassification of end points to have caused our results.
For alcoholism defined by hospital registry information,
sensitivity is likely considerably less than 100% because
many alcoholics are untreated or treated at private clinics
that are not included in the national registers. However,
specificity could be close to perfect; few nonalcoholics are
presumably diagnosed as alcoholics. In this scenario,
nondifferential misclassification is not affecting the hazard
ratio.32
Never-drinkers have not been exposed to alcohol and
hence, their drinking status cannot have been affected by
ADH1B and ADH1C genotypes. It was not possible to
separate never-drinkers from nondrinkers in this study, so
performing analyses without never-drinkers was not an
option. Potentially, this could have caused bias, but since
excluding consistent nondrinkers from analyses had vir-
tually no impact on our results, we do not consider this a
major limitation.
We modeled the amount of alcohol intake in five different
ways and alcoholism in three different ways. Hence, several
statistical tests have been performed which in some
instances call for caution. However, outcomes in this study
were not independent but merely represent similar
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Figure 2 Genotype frequencies, OR and PARs of heavy drinking and
alcoholism according to ADH1B genotype among white and East Asian
populations. Slow alcohol degradation ADH1B 1/1 genotype is pre-
dominant among Caucasians, but rare among East Asian population.
Risks of heavy drinking and alcoholism according to ADH1B 1/1 among
white and East Asian populations are comparable, but because of the
different genotype distributions in the two populations, PARs are much
higher among white population. For East Asian population, genotype
frequencies, OR and PARs are calculated from previous studies.29,30 Ref,
reference group; OR, odds ratio; PAR, population attributable risk.
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outcomes modeled differently and we chose not to adjust
for multiple comparisons.
A likely explanation for our findings is that differences in
enzyme activity from the ADH1B and ADH1C polymorphisms
result in intraindividual differences in alcohol degradation
rate and that, for a given level of alcohol intake, individuals
with fast alcohol degradation have higher levels of acet-
aldehyde and thus more unpleasant symptoms compared
with individuals with slow alcohol degradation. However,
an effect of the polymorphisms on alcohol degradation rate
in vivo has been difficult to demonstrate,33 which may have
been due to insufficiently sensitive laboratory methods. In a
more recent study which applied a more refined method for
measuring the rate of alcohol degradation, results showed a
significant difference in degradation rate according to the
ADH1B genotype.34 In further support of an in vivo effect of
the ADH1B genotype is that individuals with the most active
enzymes are consistently reported to experience more
unpleasant symptoms such as flushing when drinking
alcohol compared to individuals with the less active
enzymatic forms.35–38
Our study had several strengths. First of all, sample size
was large and provided adequate power to study associations
between the relatively rare ADH1B 1/2 genotype and several
end points, and to detect the small effect sizes associated
with the ADH1C genotypes. Furthermore, participants were
men and women from the general population, all of Danish
descent. Hence, population stratification is unlikely to have
affected our results. Alcohol drinking habits were described
in several dimensions and information on alcoholism was
obtained from two independent sources (questionnaire and
hospital registry information). All end points were assessed
independently from genotyping and participants were
unaware of the purpose of this study when enrolled.
In conclusion, our data suggest that alcoholism and
alcohol drinking habits are partly predictable from ADH1B
and ADH1C genotypes. Results for men and women were
comparable and, as expected, effects of ADH1B were larger
than effects of ADH1C.
Methods
Study population
Our data originate from The Copenhagen City Heart Study,
which is a series of studies conducted in the Danish general
population. Examinations consisted of interview and physical
examination, and more especially, blood was given for DNA
purification at the examination that was performed during
1991–1994. All participants gave written consent and the
ethics committee for Copenhagen and Frederiksberg ap-
proved the study (no. 100.2039/91). Enrolment and exam-
ination procedures have been described in more detail
elsewhere.39,40 Of the 17 180 individuals who were invited
to the 1991–1994 examination, 10 135 participated, 9259
gave blood and 9222 were successfully genotyped. Eligibility
criterion for participation was Danish citizenship and
therefore, the Copenhagen City Heart Study does not reflect
the ethnic admixture of Copenhagen (the proportion of
inhabitants with foreign citizenship was 8% in 1994).
However, even a few participants of foreign ethnicity could
potentially confound our results since the fast alcohol
degradation ADH1B  2 allele is rare among white population
and quite frequent in other populations. Information on
ethnicity was not assessed at the examinations, and hence
information on birthplace was obtained from the Civil
Registration System. Participants born in Asia, Africa, the
Middle East, South America or Greenland were excluded
from further study (n¼211). In all, 9080 individuals were
eligible for analyses, some of whom also participated in the
examinations during 1981–1983 (n¼6615) and during
2001–2003 (n¼ 4684).
Genotyping procedures
The ADH1B 2 allele (rs1229984, Arg47His in exon 3) and
ADH1C 2 allele (rs698, Ile3490Val in exon 8) were identi-
fied by means of duplex polymerase chain reaction followed
by Nanogen microelectronic chip technology (Nanogen
NMW 1000 Nanochip Molecular Biology Workstation)41
using standard conditions (details available from authors).
In a validation study, the accuracy of the Nanogen method
was found to be comparable to restriction fragment length
polymorphism.42
End points
Questions on drinking habits were included in the ques-
tionnaire at the examinations during 1981–1983, 1991–
1994 and 2001–2003. Amount of alcohol intake was
reported as usual intake of weekly beers, wine and spirits.
Assuming one drink to be equal to 12 g of pure alcohol, a
measure of total weekly intake was calculated. We defined
heavy drinking as drinking more than 21 drinks per week
for men and 14 drinks per week for women, and excessive
drinking as drinking more than 35 drinks per week for men
and 21 drinks per week for women.43 Participants were
defined as daily drinkers if they reported to drink alcohol
every day.
We defined alcoholism from questionnaire as well as from
hospital discharge information. The former definition was
taken from the 1991–1994 questionnaire, which included a
screening test for alcoholism (10 question version of the
brief MAST44). The test included questions such as ‘Do you
feel you are a normal drinker?’ and ‘Have you ever gone to
anyone for help about your drinking?’ Test scores ofX5 and
of X10 were used as dichotomized end points. Information
on hospitalizations for alcoholism was obtained from the
Danish Hospital Discharge Register where all hospitaliza-
tions in Denmark, classified according to the World Health
Organization’s International Classification of Diseases (ICD)
are registered.45 The following diagnoses indicative of
hospitalization due to alcoholism were obtained: ICD-8
codes 303.09–303.99 and ICD-10 codes F10.1–F10.4.
Statistical analyses
All statistical models included ADH1B and ADH1C geno-
types, age and years of school education using the SAS/Stat
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software (version 8.02). ADH1B  2 heterozygotes were
combined with ADH1B 2 homozygotes (n¼ 6). Estimated
haplotype frequencies were calculated by Hplus.46,47 Link-
age disequilibrium was expressed as r2 and D0.48,49
To study the association between ADH1B and ADH1C
genotypes and amount of alcohol intake, the correlated
mixed distribution model was applied (Mixcorr macro50).
This model handles data with clumping at zero and a
lognormal distribution for nonzero values, and contains
components to model the probability of a nonzero value
and the mean of nonzero values, allowing for repeated
measurements using random effects.50 This means that if a
variable affects the mean amount by affecting both the
probability of occurrence of a nonzero value and also the
mean of a nonzero value, these effects can be separated and
quantified. Hence, two estimates are produced from this
model: the OR for having a nonzero alcohol intake (that is,
for not being a non-drinker) and the mean amount of
alcohol intake among those with a nonzero intake.
To study the association between ADH1B and ADH1C
genotypes and daily, heavy and excessive drinking, we
applied logistic regression allowing for repeated measure-
ments using random effects (proc nlmixed). We applied
unconditional logistic regression to study associations
between ADH1B and ADH1C genotypes and dichotomized
brief MAST score (proc genmod).
Risk estimates for alcoholism defined from hospitaliza-
tions were computed by means of Cox proportional hazard
regression (proc phreg). Age was used as the time axis and
analyses were corrected for delayed entry. Vital status of the
participants was obtained from the National Central Person
Register. The observation time for each participant was the
period from participation in the Copenhagen City Heart
Study, until date of alcoholism, death, emigration outside
Denmark or January 1, 2004, whichever came first. We had
100% follow-up.
Population attributable risk was calculated as (proportion
of exposed in the population  (OR1))/(proportion of
exposed in the population  (OR1)þ1).51
Abbreviations
ADH alcohol dehydrogenase
bMAST brief Michigan Alcoholism Screening Test
OR odds ratio
PAR population attributable risk
Ref Reference group
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